Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-01 Purchase | 2024-07-01 5:00 pm | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director | 17,000 | $1.2159 | $20,670 | 304,458 (Indirect Direct) | View |
| 2022-05-25 Purchase | 2022-05-27 4:10 pm | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I CHIEF EXECUTIVE OFFICER | 2,482 | $2.58 | $6,404 | 232,558 (Indirect Direct) | View |
| 2022-05-19 Purchase | 2022-05-23 4:41 pm | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I CHIEF EXECUTIVE OFFICER | 13,256 | $2.7938 | $37,034 | 230,076 (Indirect Direct) | View |
| 2021-08-16 Purchase(A) | 2022-04-21 4:50 pm | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Chief Executive Officer | 4,922 | $7.866 | $38,716 | 216,820 (Direct) | View |
| 2022-03-01 Purchase | 2022-03-07 7:13 pm | NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director | 3,880 | $1.6372 | $6,352 | 72,707 (Indirect Direct) | View |
| 2021-04-26 Purchase | 2021-04-27 4:03 pm | NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director | 5,000 | $5 | $25,000 | 68,827 (Indirect Direct) | View |
| 2020-04-30 Purchase | 2020-05-04 09:56 am | NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director | 10,833 | $6 | $64,998 | 63,827 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-09-20 Exercise | 2023-09-22 4:34 pm | N/A N/A | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director | 54,900 | $0 | 287,458 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:14 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director | 384,300 | $0 | 384,300 (Direct) | View |
| 2022-09-09 Option Award | 2022-09-12 5:01 pm | N/A 2032-09-09 | NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director | 37,600 | $0 | 37,600 (Direct) | View |
Ownership(A) | 2022-04-21 4:47 pm | N/A 2030-12-15 | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Chief Executive Officer | 0 | $0 | 26,424 (Direct) | View |
| 2021-08-19 Option Award | 2021-09-17 4:16 pm | N/A 2031-08-19 | NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director | 38,135 | $0 | 38,135 (Direct) | View |
| 2021-08-16 Exercise | 2021-08-17 9:03 pm | N/A N/A | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director | 4,922 | $7.866 | 216,820 (Direct) | View |
Ownership | 2021-03-17 8:46 pm | N/A N/A | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Chief Executive Officer | 0 | $0 | 211,898 (Direct) | View |
| 2020-09-09 Option Award | 2020-09-11 5:20 pm | N/A 2030-09-09 | NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director | 14,634 | $0 | 14,634 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 7:10 pm | N/A 2030-02-28 | ADMA BIOLOGICS INC. | ADMA | RICHMAN ERIC I Director | 22,500 | $0 | 59,030 (Direct) | View |